We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+3.43%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.79B
AUM Growth
+$618M
Cap. Flow
+$595M
Cap. Flow %
33.32%
Top 10 Hldgs %
16.68%
Holding
4,499
New
1,229
Increased
1,153
Reduced
1,264
Closed
790

Sector Composition

Rank Sector Weight
1 Technology 13.59%
2 Financials 10.04%
3 Healthcare 8.35%
4 Industrials 7.34%
5 Consumer Discretionary 7.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HRL icon
2701
Hormel Foods
HRL
$13.8B
$12K ﹤0.01%
+315
New +$11.3K
IPI icon
2702
Intrepid Potash
IPI
$469M
$12K ﹤0.01%
+292
New +$12.8K
IWY icon
2703
iShares Russell Top 200 Growth ETF
IWY
$16.6B
$12K ﹤0.01%
157
-6,216
-98% -$477K
LZB icon
2704
La-Z-Boy
LZB
$1.69B
$12K ﹤0.01%
+400
New +$12.3K
LITS
2705
Lite Strategy Inc
LITS
$30.9M
$12K ﹤0.01%
147
+94
+177% +$5.76K
OPY icon
2706
Oppenheimer Holdings
OPY
$1.2B
$12K ﹤0.01%
425
-18,175
-98% -$506K
TBPH icon
2707
Theravance Biopharma
TBPH
$877M
$12K ﹤0.01%
523
-137
-21% -$3.25K
TS icon
2708
Tenaris
TS
$26.8B
$12K ﹤0.01%
325
-1,100
-77% -$40.7K
USA icon
2709
Liberty All-Star Equity Fund
USA
$1.85B
$12K ﹤0.01%
+1,834
New +$11.7K
WERN icon
2710
Werner Enterprises
WERN
$2.25B
$12K ﹤0.01%
324
-2,176
-87% -$80.9K
HEWG
2711
DELISTED
iShares Currency Hedged MSCI Germany ETF
HEWG
$12K ﹤0.01%
433
-745
-63% -$21.3K
DLA
2712
DELISTED
Delta Apparel Inc.
DLA
$12K ﹤0.01%
614
+389
+173% +$7.27K
UMPQ
2713
DELISTED
Umpqua Holdings Corp
UMPQ
$12K ﹤0.01%
514
-8,147
-94% -$190K
CDR
2714
DELISTED
Cedar Realty Trust, Inc
CDR
$12K ﹤0.01%
+373
New +$10.3K
TREC
2715
DELISTED
Trecora Resources
TREC
$12K ﹤0.01%
+799
New +$10.9K
FNJN
2716
DELISTED
Finjan Holdings, Inc.
FNJN
$12K ﹤0.01%
+3,373
New +$10.1K
ENFC
2717
DELISTED
Entegra Financial Corp.
ENFC
$12K ﹤0.01%
406
+239
+143% +$6.82K
CDOR
2718
DELISTED
Condor Hospitality Trust, Inc. Common Stock
CDOR
$12K ﹤0.01%
1,163
+33
+3% +$335
DTYS
2719
DELISTED
iPath US Treasury 10-year Bear ETN
DTYS
$12K ﹤0.01%
522
+240
+85% +$5.52K
OMED
2720
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$12K ﹤0.01%
5,291
+5,212
+6,597% +$15.2K
ASA
2721
ASA Gold and Precious Metals
ASA
$1.09B
$11K ﹤0.01%
1,115
-3,546
-76% -$37.2K
BHF icon
2722
Brighthouse Financial
BHF
$3.5B
$11K ﹤0.01%
267
-5,426
-95% -$261K
CEE
2723
Central and Eastern Europe Fund
CEE
$139M
$11K ﹤0.01%
479
+79
+20% +$1.9K
CRWS icon
2724
Crown Crafts
CRWS
$32.3M
$11K ﹤0.01%
1,910
+724
+61% +$4.21K
CSBR icon
2725
Champions Oncology
CSBR
$72.1M
$11K ﹤0.01%
1,799
+46
+3% +$221

Similar funds

Tower Research Capital (TRC)'s Q2 2018 Portfolio in Review

As of Q2 2018, Tower Research Capital (TRC) held 4,499 positions worth $1.79B, up 53% from $1.17B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Tower Research Capital (TRC) deployed $595M of net new capital in Q2 2018, opening 1,229 new positions and adding to 1,153 existing holdings. Its largest new stake was JPMorgan Chase: 180,678 shares worth $18.8M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 4.7% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $31.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2018 buy was JPMorgan Chase: 180,678 shares worth $18.8M.
  • Tower Research Capital (TRC) added most to Apple in Q2 2018, an estimated $51.7M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2018 reduction was iShares MSCI EAFE ETF, cutting an estimated $31.8M.
  • Tower Research Capital (TRC) fully exited State Street SPDR Dow Jones REIT ETF in Q2 2018, selling an estimated $6.85M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 17% of its $1.79B portfolio in Q2 2018.
  • Tower Research Capital (TRC) opened 1,229 new positions and closed 790 in Q2 2018.
  • Tower Research Capital (TRC)'s portfolio value rose 53% quarter-over-quarter to $1.79B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2018, filed 15 Aug 2018.